Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Aptus Pharma Ltd. IPO is a book build issue of ₹13.02 crores. The issue is entirely a fresh issue of 0.19 crore shares of ₹13.02 crore.
Aptus Pharma IPO bidding started from Sep 23, 2025 and ended on Sep 25, 2025. The allotment for Aptus Pharma IPO was finalized on Sep 26, 2025. The shares got listed on BSE SME on Sep 30, 2025.
Aptus Pharma IPO price band is set at ₹70.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹2,80,000.00 (4,000 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (6,000 shares), amounting to ₹4,20,000.
Interactive Financial Services Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Market-Hub Stock Broking Pvt.Ltd..
Refer to Aptus Pharma IPO RHP for detailed Information.
| IPO Date | September 23, 2025 to September 25, 2025 |
| Listing Date | September 30, 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹65 to ₹70 per share |
| Issue Price Final | ₹70 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 18,60,000 shares (aggregating up to ₹13.02 Cr) |
| Reserved for Market Maker | 94,000 shares Market-Hub Stock Broking Pvt.Ltd. (aggregating up to ₹0.6580 Cr) |
| Net Offered to Public | 17,66,000 shares (aggregating up to ₹12.36 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 50,00,000 shares |
| Share Holding Post Issue | 68,60,000 shares |
Aptus Pharma IPO offers total 18,60,000 shares. Out of which 8,80,000 (47.31%) allocated to QIB, 3,52,000 (18.92%) allocated to QIB (Ex- Anchor), 2,66,000 (14.30%) allocated to NII 6,20,000 (33.33%) allocated to RII and 5,28,000 (28.39%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 94,000 (5.05%) |
| QIB Shares Offered | 8,80,000 (47.31%) |
| − Anchor Investor Shares Offered | 5,28,000 (28.39%) |
| − QIB (Ex. Anchor) Shares Offered | 3,52,000 (18.92%) |
| NII (HNI) Shares Offered | 2,66,000 (14.30%) |
| − bNII > ₹10L | 1,78,000 (9.57%) |
| − sNII < ₹10L | 88,000 (4.73%) |
| Retail Shares Offered | 6,20,000 (33.33%) |
| Total Shares Offered | 18,60,000 (100.00%) |
Aptus Pharma IPO raises ₹3.70 crore from anchor investors. Aptus Pharma IPO Anchor bid date is September 22, 2025. Aptus Pharma IPO Anchor Investors list
| Bid Date | September 22, 2025 |
| Shares Offered | 5,28,000 |
| Anchor Portion Size (In Cr.) | 3.70 |
| Anchor lock-in period end date for 50% shares (30 Days) | October 26, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | December 25, 2025 |
Aptus Pharma IPO opens on September 23, 2025, and closes on September 25, 2025.
| IPO Open Date | Tue, Sep 23, 2025 |
| IPO Close Date | Thu, Sep 25, 2025 |
| Tentative Allotment | Fri, Sep 26, 2025 |
| Initiation of Refunds | Mon, Sep 29, 2025 |
| Credit of Shares to Demat | Mon, Sep 29, 2025 |
| Tentative Listing Date | Tue, Sep 30, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Sep 25, 2025 |
Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,80,000 |
| Individual investors (Retail) (Max) | 2 | 4,000 | ₹2,80,000 |
| S-HNI (Min) | 3 | 6,000 | ₹4,20,000 |
| S-HNI (Max) | 7 | 14,000 | ₹9,80,000 |
| B-HNI (Min) | 8 | 16,000 | ₹11,20,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.
Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.
As of March 31, 2025, the company had 70 employees.
Competitive Strengths
Aptus Pharma Limited's revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 21.92 | 10.03 | 6.22 |
| Total Income | 24.64 | 17.88 | 13.90 |
| Profit After Tax | 3.10 | 0.80 | 0.19 |
| EBITDA | 4.76 | 1.49 | 0.57 |
| Net Worth | 6.97 | 1.77 | 0.97 |
| Reserves and Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowing | 10.36 | 5.31 | 2.21 |
| Amount in ₹ Crore | |||
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 44.50% |
| ROCE | 45.66% |
| Debt/Equity | 1.49 |
| RoNW | 44.50% |
| EBITDA Margin | 19.31% |
| Market Capitalization | ₹48.02 Cr. |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 6.20 | 4.52 |
| P/E (x) | 11.29 | 15.49 |
The Company Aptus Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Capital Expenditure for Office Premises with furniture and Industrial Racks | 1.63 |
| 2 | Working Capital | 8.00 |
| 3 | General corporate purposes | 1.91 |
[Dilip Davda] APL is engaged in the business of marketing and distribution of finished pharma formulations. It does not have its own manufacturing unit, but does the business on third party contract. The company posted growth in its top and bottom lines for the reported period, however, sudden boost in bottom line for FY25 raise eyebrows and concern over its sustainability. Based on its recent financial data, the issue appears aggressively priced. Small paid-up equity capital post-IPO indicates longer gestation period for migration. Only well-informed/risk seekers/cash surplus investors may park moderate funds for long term Read detail review...
| Listing Date | September 30, 2025 |
| BSE Script Code | 544529 |
| NSE Symbol | |
| ISIN | INE15XJ01010 |
| Final Issue Price | ₹70 per share |
| BSE Listing Group | MT (Trade to Trade) |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹70.00 |
| Open | ₹80.80 |
| Low | ₹80.80 |
| High | ₹84.84 |
| Last Trade | ₹84.84 |
Aptus Pharma Ltd.
Ashutosh Buildcon, Opp. Slok - 2,
Nr. Harikrupa Logistic Park,
Aslali, Ahmedabad, Daskroi,
Ahmedabad, Gujarat, 382427
Phone: +91 76004 27827
Email: info@aptuspharma.com
Website: https://aptus-pharma.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Aptus Pharma IPO is a SME IPO of 18,60,000 equity shares of the face value of ₹10 aggregating up to ₹13.02 Crores. The issue is priced at ₹70 per share. The minimum order quantity is 2000.
The IPO opens on September 23, 2025, and closes on September 25, 2025.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Aptus Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Aptus Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Aptus Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Aptus Pharma IPO opens on September 23, 2025 and closes on September 25, 2025.
Aptus Pharma IPO lot size is 2000, and the minimum amount required for application is ₹2,80,000, with 2 lots being the minimum application size.
You can apply in Aptus Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Aptus Pharma IPO will be done on Friday, September 26, 2025, and the allotted shares will be credited to your demat account by Monday, September 29, 2025. Check the Aptus Pharma IPO allotment status.
The Aptus Pharma IPO listing date is on Tuesday, September 30, 2025.
Useful Articles
RHP